These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36263185)

  • 1. Identification of Gαi3 as a novel molecular therapeutic target of cervical cancer.
    Zhang J; Yin DP; Zhang Y; Zhang JN; Yang Y; Zhang ZQ; Zhou L; Lv Y; Huang HW; Cao C
    Int J Biol Sci; 2022; 18(15):5667-5680. PubMed ID: 36263185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Gαi3 as a promising target for osteosarcoma treatment.
    Bian ZJ; Shan HJ; Zhu YR; Shi C; Chen MB; Huang YM; Wang XD; Zhou XZ; Cao C
    Int J Biol Sci; 2022; 18(4):1508-1520. PubMed ID: 35280670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Gαi3 as a promising molecular oncotarget of pancreatic cancer.
    Jiang JZ; Qiao YB; Zhu XR; Gu QH; Lu JJ; Ye ZY; Xu L; Liu YY
    Cell Death Dis; 2024 Sep; 15(9):699. PubMed ID: 39349432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpressed Gαi1 exerts pro-tumorigenic activity in nasopharyngeal carcinoma.
    Yin DP; Zhang H; Teng H; Zhang D; Chen P; Xie L; Liu JS
    Cell Death Dis; 2023 Dec; 14(12):792. PubMed ID: 38049415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SLC5A3 is important for cervical cancer cell growth.
    Li L; Shen FR; Cheng Q; Sun J; Li H; Sun HT; Cai X; Chen M; Yang B; Wang L; Xu L
    Int J Biol Sci; 2023; 19(9):2787-2802. PubMed ID: 37324953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of matrix-remodeling associated 5 as a possible molecular oncotarget of pancreatic cancer.
    Peng SQ; Zhu XR; Zhao MZ; Zhang YF; Wang AR; Chen MB; Ye ZY
    Cell Death Dis; 2023 Feb; 14(2):157. PubMed ID: 36828810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial cell-specific molecule 1 drives cervical cancer progression.
    Lu J; Liu Q; Zhu L; Liu Y; Zhu X; Peng S; Chen M; Li P
    Cell Death Dis; 2022 Dec; 13(12):1043. PubMed ID: 36522312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The critical role of Gαi3 in oral squamous cell carcinoma cell growth.
    Li Q; Huang Z; Li Z; Fan J; Li K
    Cell Death Discov; 2024 Oct; 10(1):420. PubMed ID: 39349425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The sodium/myo-inositol co-transporter SLC5A3 promotes non-small cell lung cancer cell growth.
    Cui Z; Mu C; Wu Z; Pan S; Cheng Z; Zhang ZQ; Zhao J; Xu C
    Cell Death Dis; 2022 Jun; 13(6):569. PubMed ID: 35760803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of REG3A promotes tumorigenic behavior in triple negative breast cancer cells.
    Jin X; Yang S; Lu X; Chen X; Dai W
    Breast Cancer Res; 2024 Jun; 26(1):92. PubMed ID: 38840145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the mitochondrial protein YME1L to inhibit osteosarcoma cell growth in vitro and in vivo.
    Sun X; Shi C; Dai J; Zhang MQ; Pei DS; Yang L
    Cell Death Dis; 2024 May; 15(5):346. PubMed ID: 38769124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-199a Inhibits Cell Proliferation, Migration, and Invasion and Activates AKT/mTOR Signaling Pathway by Targeting B7-H3 in Cervical Cancer.
    Yang X; Feng KX; Li H; Wang L; Xia H
    Technol Cancer Res Treat; 2020; 19():1533033820942245. PubMed ID: 32856542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADCK1 is a potential therapeutic target of osteosarcoma.
    Zhuo BB; Zhu LQ; Yao C; Wang XH; Li SX; Wang R; Li Y; Ling ZY
    Cell Death Dis; 2022 Nov; 13(11):954. PubMed ID: 36371387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-99b suppresses human cervical cancer cell activity by inhibiting the PI3K/AKT/mTOR signaling pathway.
    Li YJ; Wang Y; Wang YY
    J Cell Physiol; 2019 Jun; 234(6):9577-9591. PubMed ID: 30480801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Derlin1 functions as an oncogene in cervical cancer via AKT/mTOR signaling pathway.
    Li L; Liu M; Zhang Z; Zhang W; Liu N; Sheng X; Wei P
    Biol Res; 2019 Feb; 52(1):8. PubMed ID: 30808417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the mitochondrial protein ADCK2 as a therapeutic oncotarget of NSCLC.
    Zhang JZ; Liu J; Xu YX; Pu WY; Shen MJ; Jiang KQ; Yang YL; Lu J; Deng Z; Yang Y; Xu WH
    Int J Biol Sci; 2022; 18(16):6163-6175. PubMed ID: 36439873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of FHL2 promotes tumorigenesis in cervical cancer and is correlated with poor prognosis.
    Jin X; Jiao X; Jiao J; Zhang T; Cui B
    Gene; 2018 Aug; 669():99-106. PubMed ID: 29800735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BMX/Etk promotes cell proliferation and tumorigenicity of cervical cancer cells through PI3K/AKT/mTOR and STAT3 pathways.
    Li Y; Cui N; Zheng PS; Yang WT
    Oncotarget; 2017 Jul; 8(30):49238-49252. PubMed ID: 28514765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mitochondrial protein YME1 Like 1 is important for non-small cell lung cancer cell growth.
    Xia Y; He C; Hu Z; Wu Z; Hui Y; Liu YY; Mu C; Zha J
    Int J Biol Sci; 2023; 19(6):1778-1790. PubMed ID: 37063426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation.
    Zheng Y; Xie L; Xu S; Yan W; Zhang H; Meng Y; Liu J; Wei X
    Mol Cell Biochem; 2021 Nov; 476(11):4031-4044. PubMed ID: 34244973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.